KROS Keros Therapeutics, Inc.
Price Chart
Executive Summary
Two Keros Therapeutics directors sold a combined $56K in open-market sales on June 4, 2026, following a round of non-cash stock grants to the same directors on June 3. The sales are trivial relative to the $204M market cap (0.03%) and are likely liquidity-driven after the grants, not a bearish signal. The cluster is not amplified by any cross-filing context (no earnings, offering, or late-filing events nearby).
Key Financial Metrics
Actionable Insight
The sales are routine and likely driven by tax or liquidity needs following the director stock grants. No bearish read-through. Monitor for any C-suite insider sales or a material increase in sale volume (>0.5% of market cap) before adjusting stance.
Key Facts
- Two directors (Seth Alpna and Knowles Julius) each sold 2,625 shares on June 4, 2026, at ~$10.72-$10.73, totaling $56,306.
- Both sales occurred one day after each director received non-cash stock grants (7,433 and 7,142 shares respectively) on June 3, 2026.
- Total sale value of $56K represents only 0.03% of KROS's $204M market cap — well below the 0.1% materiality threshold.
- No C-suite executives participated in the sales; only two directors sold.
- No recent earnings, offering, restructuring, or late-filing events are present to amplify the cluster's signal.
Financial Impact
Total open-market sales of $56,306, or 0.03% of market cap — immaterial.
Risk Factors
- If additional insiders (especially C-suite) begin selling in the coming weeks, the pattern could become more concerning.
- KROS has a history of negative T+20 returns on neutral reports (avg -2.57%), but this cluster is too small to drive that.
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-KROS-1780951066902 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 8, 2026
1d ago
|
Insider Cluster
| $9.99 awaiting T+5 | awaiting T+5 | — | $10.00 (+0.10%) |
|
May 14, 2026
26d ago
|
8-K
| $10.99 $11.22 | ▼ −2.09% | ▼ −2.81% | $10.00 (+9.01%) |
|
May 14, 2026
26d ago
|
Press Release
| $10.99 $11.22 | ▼ −2.09% | ▼ −2.81% | $10.00 (+9.01%) |
|
Apr 22, 2026
6w ago
|
DEFA14A
| $11.56 $11.10 | ▼ −3.98% | ▼ −5.46% | $10.00 (−13.49%) |
|
Apr 1, 2026
10w ago
|
144
| $11.69 $12.49 | ▲ +6.84% | ▲ +3.08% | $10.00 (−14.46%) |
|
Mar 9, 2026
13w ago
|
Press Release
| $11.35 $11.03 | ▼ −2.82% | ▼ −1.46% | $10.00 (−11.89%) |
|
Mar 4, 2026
13w ago
|
8-K
| $11.71 $10.99 | ▼ −6.15% | ▼ −3.91% | $10.00 (−14.60%) |
|
Mar 4, 2026
13w ago
|
8-K
| $11.71 $10.99 | ▼ −6.15% | ▼ −3.91% | $10.00 (−14.60%) |
|
Mar 4, 2026
13w ago
|
Press Release
| $11.71 $10.99 | ▼ −6.15% | ▼ −3.91% | $10.00 (−14.60%) |
|
Feb 28, 2026
14w ago
|
Institutional Cluster
| $13.91 $11.35 | ▼ −18.40% | ▼ −17.20% | $10.00 (−28.11%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access